1. Home
  2. SOHU vs ARMP Comparison

SOHU vs ARMP Comparison

Compare SOHU & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sohu.com Limited

SOHU

Sohu.com Limited

HOLD

Current Price

$12.23

Market Cap

361.8M

Sector

Technology

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$7.09

Market Cap

295.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOHU
ARMP
Founded
1996
N/A
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
361.8M
295.5M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
SOHU
ARMP
Price
$12.23
$7.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$20.00
$15.00
AVG Volume (30 Days)
46.0K
54.7K
Earning Date
05-18-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.61
N/A
Revenue Next Year
$3.78
N/A
P/E Ratio
$1.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.12
$1.81
52 Week High
$17.30
$14.98

Technical Indicators

Market Signals
Indicator
SOHU
ARMP
Relative Strength Index (RSI) 28.54 38.34
Support Level N/A $4.96
Resistance Level $15.99 $7.70
Average True Range (ATR) 0.44 0.65
MACD -0.04 0.01
Stochastic Oscillator 14.36 36.04

Price Performance

Historical Comparison
SOHU
ARMP

About SOHU Sohu.com Limited

Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: